Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LSP1 pseudogene 5 (LSP1P5) is a human pseudogene related to the lymphocyte specific protein 1 (LSP1) gene. By standard definition, a pseudogene is a genetic element derived from a functional gene that has lost its protein-coding ability due to mutations, truncations, or other genomic rearrangements. While some pseudogenes can exert regulatory functions at the RNA level (e.g., acting as competing endogenous RNAs or long noncoding RNAs), there is no direct evidence that LSP1P5 participates in any specific biological process or disease mechanism. It is not considered a receptor, enzyme, transporter, or active therapeutic target. References to LSP1P5 as LSP1P4 appear to be alternate or less common nomenclature, possibly reflecting historical annotation inconsistencies. The function of most pseudogenes, including LSP1P5, remains poorly characterized, and they are generally not considered canonical drug targets or biomarkers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LSP1 pseudogene 5 (LSP1P5).